TY  - JOUR 
AU  - C., Peral
AU  - CORDIDO CARBALLIDO, FERNANDO
AU  - V., Gimeno-Ballester
AU  - N., Mir
AU  - L., Sanchez-Cenizo
AU  - D., Rubio-Rodriguez
AU  - C., Rubio-Terres
PY  - 2019
SN  - 1473-7167
UR  - http://hdl.handle.net/20.500.11940/16058
AB  - Objective: To estimate the cost-effectiveness of second-line pharmacological treatments in patients with acromegaly resistant to first-generation somatostatin analogues (FG SSA) from the Spanish National Health System (NHS) perspective.Methods: A...
LA  - eng
KW  - Humans
KW  - Human Growth Hormone
KW  - Hormones
KW  - Quality-Adjusted Life Years
KW  - Markov Chains
KW  - Acromegaly
TI  - Cost-effectiveness analysis of second-line pharmacological treatment of acromegaly in Spain
DO  - 10.1080/14737167.2019.1610396
T2  - Expert review of pharmacoeconomics & outcomes research
KW  - CHUAC
VL  - 20
ER  -